Monocyte chemoattractant protein-1 messenger RNA expression in rat ischemic cortex

Area of Science:

• Neuroscience
• Immunology
• Molecular Biology

Background:

• Focal cerebral ischemia, induced by middle cerebral artery occlusion (MCAO), leads to increased cytokine/chemokine expression.
• Monocyte chemoattractant protein-1 (MCP-1) is a specific chemoattractant for monocytes, crucial in inflammatory responses.

Purpose of the Study:

• To investigate the expression of MCP-1 messenger RNA (mRNA) in ischemic brain tissue following MCAO.
• To determine if MCP-1 mRNA is upregulated in the early stages of focal cerebral ischemia.

Main Methods:

• Reverse transcription and polymerase chain reaction (RT-PCR) were used to initially detect MCP-1 mRNA.
• Northern blot analysis quantified MCP-1 mRNA expression over time in ischemic and non-ischemic brain regions after permanent and temporary MCAO with reperfusion.

Main Results:

• MCP-1 mRNA expression was significantly elevated in the ischemic cortex post-MCAO, with minimal expression in sham or non-ischemic tissue.
• Expression peaked between 12 hours and 2 days after permanent MCAO (22.7-fold increase) and was elevated for up to 5 days.
• Following MCAO with reperfusion, MCP-1 mRNA increased earlier (3 hours) and was higher in hypertensive rats compared to normotensive rats.

Conclusions:

• Induced MCP-1 mRNA expression occurs early after focal ischemia, indicating its potential role as a local chemoattractant.
• MCP-1 likely contributes to monocyte infiltration into ischemic brain tissue, potentially exacerbating stroke-related injury.
• Further research is needed to identify MCP-1's specific cellular localization within the ischemic brain.